Though RNA is viewed as a promising tool in nanotherapy, the difficulties of producing stable and long-lasting therapeutic RNA have posed challenges to research. A biomedical engineering professor has detailed the successful production of large RNA nanoparticles from smaller RNA segments. The nanoparticles had a half life of between five and 10 hours in animal models and targeted cancer cells in vivo to release therapeutics.